1647 related articles for article (PubMed ID: 10770210)
21. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
[TBL] [Abstract][Full Text] [Related]
22. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
Salvi M; Bingoye F; Chung F; Wall JR
J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
[TBL] [Abstract][Full Text] [Related]
23. Antibodies against 1D, a recombinant 64-kDa membrane protein, are associated with ophthalmopathy in patients with thyroid autoimmunity.
Bernard NF; Nygen TN; Tyutyunikov A; Stolarski C; Scalise D; Genovese C; Hayes MB; Ludgate M; Wall JR
Clin Immunol Immunopathol; 1994 Mar; 70(3):225-33. PubMed ID: 8313659
[TBL] [Abstract][Full Text] [Related]
24. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay.
Ahmann A; Baker JR; Weetman AP; Wartofsky L; Nutman TB; Burman KD
J Clin Endocrinol Metab; 1987 Mar; 64(3):454-60. PubMed ID: 2434519
[TBL] [Abstract][Full Text] [Related]
25. A 63 kDa skeletal muscle protein associated with eye muscle inflammation in Graves' disease is identified as the calcium binding protein calsequestrin.
Gunji K; Kubota S; Stolarski C; Wengrowicz S; Kennerdell JS; Wall JR
Autoimmunity; 1999; 29(1):1-9. PubMed ID: 10052680
[TBL] [Abstract][Full Text] [Related]
26. Tissue specificity and serologic reactivity of an autoantigen associated with autoimmune thyroid disease.
Ross PV; Koenig RJ; Arscott P; Ludgate M; Waier M; Nelson CC; Kaplan MM; Baker JR
J Clin Endocrinol Metab; 1993 Aug; 77(2):433-8. PubMed ID: 8345048
[TBL] [Abstract][Full Text] [Related]
27. Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema.
Arnold K; Metcalfe R; Weetman AP
J Clin Endocrinol Metab; 1995 Dec; 80(12):3430-7. PubMed ID: 8530579
[TBL] [Abstract][Full Text] [Related]
28. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy.
Nguyen B; Gopinath B; Tani J; Wescombe L; Wall JR
Autoimmunity; 2008 Aug; 41(5):372-6. PubMed ID: 18568642
[TBL] [Abstract][Full Text] [Related]
29. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR
J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy.
Salvi M; Bernard N; Miller A; Zhang ZG; Gardini E; Wall JR
Thyroid; 1991; 1(3):207-13. PubMed ID: 1824337
[TBL] [Abstract][Full Text] [Related]
31. Eye signs and serum eye muscle and collagen XIII antibodies in patients with transient and progressive thyroiditis.
Gopinath B; Ma G; Wall JR
Thyroid; 2007 Nov; 17(11):1123-9. PubMed ID: 17887926
[TBL] [Abstract][Full Text] [Related]
32. Significance of anti-eye muscle antibody in patients with thyroid-associated ophthalmopathy by quantitative western blot.
Hiromatsu Y; Sato M; Tanaka K; Shoji S; Nonaka K; Chinami M; Fukazawa H
Autoimmunity; 1992; 14(1):9-16. PubMed ID: 1299352
[TBL] [Abstract][Full Text] [Related]
33. Significance of antibodies reactive with a 64 kDa eye muscle membrane antigen in patients with thyroid autoimmunity.
Miller A; Arthurs B; Boucher A; Liberman A; Bernard N; Rodien P; Salvi M; Wall JR
Thyroid; 1992; 2(3):197-202. PubMed ID: 1422231
[TBL] [Abstract][Full Text] [Related]
34. [Muscle antigens recognized with autoantibodies in patients with Graves' ophthalmopathy].
Adler G
Endokrynol Pol; 1992; 43(1 Suppl):1-61. PubMed ID: 1345558
[TBL] [Abstract][Full Text] [Related]
35. Experimental model for ophthalmopathy in BALB/c and outbred (CD-1) mice genetically immunized with G2s and the thyrotropin receptor.
Yamada M; Li AW; West KA; Chang CH; Wall JR
Autoimmunity; 2002 Sep; 35(6):403-13. PubMed ID: 12568121
[TBL] [Abstract][Full Text] [Related]
36. Should Graves' disease be considered a collagen disorder of the thyroid, skeletal muscle and connective tissue?
Kiljanski J; Nebes V; Stachura I; Kennerdell JS; Wall JR
Horm Metab Res; 1995 Dec; 27(12):528-32. PubMed ID: 8750780
[TBL] [Abstract][Full Text] [Related]
37. Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders.
Kuroki T; Ruf J; Whelan L; Miller A; Wall JR
Clin Exp Immunol; 1985 Nov; 62(2):361-70. PubMed ID: 3841305
[TBL] [Abstract][Full Text] [Related]
38. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.
Molnár I; Balázs C
Acta Med Hung; 1991; 48(1-2):13-21. PubMed ID: 1813853
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and nonthyroid diseases.
Wu YJ; Clarke EM; Shepherd P
Thyroid; 1998 Feb; 8(2):167-74. PubMed ID: 9510126
[TBL] [Abstract][Full Text] [Related]
40. Cloning and sequencing of a novel 64-kDa autoantigen recognized by patients with autoimmune thyroid disease.
Dong Q; Ludgate M; Vassart G
J Clin Endocrinol Metab; 1991 Jun; 72(6):1375-81. PubMed ID: 2026759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
